VasoDynamics Ltd 

VasoDynamics Ltd


Ningfeng Fiona Li (See Profile)




Development, market readiness, clinical trial


United Kingdom

First-in-kind, patient-friendly, cost-effective, preventive drug for radiotherapy-induced oral damage.

Global patents protection, orphan designation potential, significant unmet needs with billion dollar addressable market

Strong science with proven MoA, successful pre-clinical proof-of-principle, successful initial clinical experiences

IP Type Status Time Countries Link What protects?
Patent Approved

This information is confidential, do not share or copy.

Under evaluation at least till: 22nd March

If you want to have more information or you want to review the project, you have to login or register


©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

Aviso de cookies

Log in with your credentials


Forgot your details?

Create Account

Skip to toolbar